Diabetic Peripheral Neuropathy News and Research

RSS
According to the National Institute of Diabetes & Digestive & Kidney Diseases, approximately half of those with diabetes have some form of nerve damage, or neuropathy, but not all will develop symptoms. While nerve problems can occur at any time, the highest rates are among those who have had diabetes for at least 25 years. People who have had problems controlling their blood sugar levels, have high blood pressure, are overweight, have high levels of blood fat, or are over the age of 40, may also have a greater risk of developing diabetic peripheral neuropathy. Symptoms can include numbness, tingling or pain and weakness in the toes, feet, legs, hands, arms and fingers. These symptoms are often worse at night.
Scientific Statement captures evolving understanding of microvascular complications related to diabetes

Scientific Statement captures evolving understanding of microvascular complications related to diabetes

Antidepressants and anti-seizure drugs can effectively treat diabetic nerve pain, research finds

Antidepressants and anti-seizure drugs can effectively treat diabetic nerve pain, research finds

Person's ‘brain speed’ may matter more than other risk factors for geriatric falls

Person's ‘brain speed’ may matter more than other risk factors for geriatric falls

Scientists discover underlying mechanisms of nerve damage

Scientists discover underlying mechanisms of nerve damage

Nuvo Research announces topline results from WF10 Phase 2 trial for treatment of allergic rhinitis

Nuvo Research announces topline results from WF10 Phase 2 trial for treatment of allergic rhinitis

Findings could lead to treatments for chronic pain caused by nerve damage

Findings could lead to treatments for chronic pain caused by nerve damage

Depomed acquires U.S. rights to NUCYNTA franchise from Janssen Pharmaceuticals

Depomed acquires U.S. rights to NUCYNTA franchise from Janssen Pharmaceuticals

Sildenafil drug may effectively relieve nerve damage in men with long-term diabetes

Sildenafil drug may effectively relieve nerve damage in men with long-term diabetes

NeuroMetrix receives marketing certification from TÜV SÜD Japan for NC-stat DPNCheck

NeuroMetrix receives marketing certification from TÜV SÜD Japan for NC-stat DPNCheck

NeuroMetrix announces marketing launch of NC-Stat DPNCheck in Japan

NeuroMetrix announces marketing launch of NC-Stat DPNCheck in Japan

Corneal nerve fiber assessment has potential to monitor peripheral neuropathy induced by HIV

Corneal nerve fiber assessment has potential to monitor peripheral neuropathy induced by HIV

Researcher wins 2014 Abraham White Distinguished Science Award for contributions in treatment of neurological diseases

Researcher wins 2014 Abraham White Distinguished Science Award for contributions in treatment of neurological diseases

Study provides insight into the mechanisms underlying diabetic peripheral neuropathy

Study provides insight into the mechanisms underlying diabetic peripheral neuropathy

NC-stat DPNCheck is a fast, accurate point-of-care test for diabetic peripheral neuropathy

NC-stat DPNCheck is a fast, accurate point-of-care test for diabetic peripheral neuropathy

Pfizer announces top-line results from phase 3b studies with Lyrica Capsules

Pfizer announces top-line results from phase 3b studies with Lyrica Capsules

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

NeuroMetrix announces business and financial highlights for second quarter

NeuroMetrix announces business and financial highlights for second quarter

First consensus guidelines for use of neurostimulation in chronic pain

First consensus guidelines for use of neurostimulation in chronic pain

NeuroMetrix fourth quarter total revenues decrease to $1.5 million

NeuroMetrix fourth quarter total revenues decrease to $1.5 million

Diabetic peripheral neuropathy risk highlighted in children

Diabetic peripheral neuropathy risk highlighted in children